New shareholder structure

31. August 2022

We are happy to announce that Science Holding GmbH represented by Dr. Jürgen Schumacher is now shareholder of CureDiab Metabolic Research GmbH. As a co-founder of QUIAGEN, Evotec Biosystems and several other companies, Jürgen has been engaged in the development of biotechnology in North-Rhine Westphalia for more than 30 years. His expertise will be instrumental for the future of CureDiab.